Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab

NCT05928897 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Disitamab Vedotin combined with Sintilimab

Sponsor

Xiangya Hospital of Central South University